These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 32611218

  • 1. Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect.
    Xu M, Li G, Zhang H, Chen X, Li Y, Yao Q, Xie M.
    Drug Deliv; 2020 Dec; 27(1):983-995. PubMed ID: 32611218
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M, Teng L, Wang Y, Zhang J, Sun X.
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [Abstract] [Full Text] [Related]

  • 4. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J, Zhang L, Chen Z, Mao G, Gao Z, Lai X, Zhu X, Zhu J.
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
    Song S, Mao G, Du J, Zhu X.
    Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
    [Abstract] [Full Text] [Related]

  • 7. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y, Pan L, Jiang M, Li D, Jin L.
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [Abstract] [Full Text] [Related]

  • 8. Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.
    Kamel AE, Fadel M, Louis D.
    Int J Nanomedicine; 2019 May; 14():5073-5085. PubMed ID: 31371948
    [Abstract] [Full Text] [Related]

  • 9. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H, Geng D, Liu H, Li Z, Cao J.
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [Abstract] [Full Text] [Related]

  • 10. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C, Ge X, Wang L.
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [Abstract] [Full Text] [Related]

  • 11. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F, Yu N, Jiao Y, Hong W, Zhou K, Ji X, Yuan H, Wang H, Li A, Wang G, Yang G.
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [Abstract] [Full Text] [Related]

  • 12. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
    Rashidzadeh H, Salimi M, Sadighian S, Rostamizadeh K, Ramazani A.
    Curr Drug Deliv; 2019 Dec; 16(10):923-930. PubMed ID: 31663477
    [Abstract] [Full Text] [Related]

  • 13. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X.
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [Abstract] [Full Text] [Related]

  • 14. Development of nanocubosomes co-loaded with dual anticancer agents curcumin and temozolomide for effective Colon cancer therapy.
    Almoshari Y, Iqbal H, Razzaq A, Ali Ahmad K, Khan MK, Saeed Alqahtani S, Hadi Sultan M, Ali Khan B.
    Drug Deliv; 2022 Dec; 29(1):2633-2643. PubMed ID: 35942514
    [Abstract] [Full Text] [Related]

  • 15. Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells.
    Zhao C, Zhu X, Yang H, Tan J, Gong R, Mei C, Cai X, Su Z, Kong F.
    Biomed Mater; 2024 Aug 22; 19(5):. PubMed ID: 39134023
    [Abstract] [Full Text] [Related]

  • 16. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W, Song Y, Song W, Liu Y, Liu Z, Zhang D, Tang Z, Bai O.
    Sci Rep; 2020 May 12; 10(1):7832. PubMed ID: 32398729
    [Abstract] [Full Text] [Related]

  • 17. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
    Tian C, Asghar S, Wu Y, Chen Z, Jin X, Yin L, Huang L, Ping Q, Xiao Y.
    Int J Nanomedicine; 2017 May 12; 12():7897-7911. PubMed ID: 29138557
    [Abstract] [Full Text] [Related]

  • 18. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
    Ruttala HB, Ko YT.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():419-426. PubMed ID: 25797481
    [Abstract] [Full Text] [Related]

  • 19. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
    Kim CH, Kang TH, Kim BD, Lee TH, Yoon HY, Goo YT, Choi YS, Kang MJ, Choi YW.
    Int J Pharm; 2020 Jun 15; 583():119393. PubMed ID: 32376445
    [Abstract] [Full Text] [Related]

  • 20. Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.
    Zhang J, Xiao X, Zhu J, Gao Z, Lai X, Zhu X, Mao G.
    Int J Nanomedicine; 2018 Jun 15; 13():3039-3051. PubMed ID: 29861635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.